-
Atrial Natriuretic Peptide: Evidence-Led Use
2026-08-13
A practical, evidence-led guide to Atrial Natriuretic Peptide and ANP peptide hormone research. It connects product identity, cardiovascular assay design, storage decisions, and lessons from an adiponectin neuroinflammation study without overstating cross-domain evidence.
-
CBD, FAAH, and Orofacial Inflammatory Pain
2026-08-12
A 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce both inflammatory orofacial nociception and pain-associated affective and cognitive deficits in mice. Its main contribution is a multilevel mechanism linking peripheral FAAH and inflammatory signaling with central endocannabinoid, trigeminal, and amygdala serotonin activity.
-
Lisinopril dihydrate: Assay Logic for ACE Studies
2026-08-12
Lisinopril dihydrate is a long-acting ACE inhibitor for dissecting renin–angiotensin signaling in cardiovascular and renal models. This guide translates comparative peptidase-inhibitor evidence into practical assay design, controls, and interpretation strategies.
-
25-Hydroxycholesterol Reprograms Tumor Macrophages
2026-08-11
The 2024 Immunity study identifies CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that activates lysosomal AMPKα and reinforces STAT6-dependent macrophage suppression. Its mechanistic and therapeutic findings connect cholesterol metabolism with T-cell exclusion and suggest that targeting CH25H may improve anti-PD-1 responses.
-
Nanoparticle Uptake by Human Corneal Epithelial Cells
2026-08-11
Azadi and David systematically linked PLGA nanoparticle size and surface chemistry to uptake mechanisms in human corneal epithelial cells. Their in vitro model showed that energy-dependent endocytosis predominated, with macropinocytosis and caveolae-mediated uptake contributing most strongly, while particle size and PEGylation produced distinct uptake profiles.
-
5-Methyl-CTP: From RNA Chemistry to Translation
2026-08-10
A translational framework for using 5-Methyl-CTP to improve mRNA quality while connecting nucleotide engineering with emerging delivery platforms, including OMV-based personalized cancer vaccines.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit
2026-08-09
A scenario-based guide to using HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit, SKU K1061, for fluorescent RNA probe preparation and molecular interpretation of viability, proliferation, and cytotoxicity experiments. It covers probe design, T7 transcription, Cy3-UTP optimization, controls, data interpretation, and practical product selection.
-
Mianserin HCl: Applied Assay Workflows
2026-08-08
Mianserin HCl supports receptor-signaling, cytotoxicity, and cyclodextrin-complexation workflows rather than serving only as a conventional antidepressant research compound. This guide translates the reference study into practical controls, concentration screens, troubleshooting steps, and cross-domain assay decisions.
-
iRGD-RBC Membranes Improve Neuroblastoma PDT
2026-08-07
Wu and colleagues developed iRGD-functionalized red blood cell membrane vesicles to improve TPOR delivery and photodynamic therapy in neuroblastoma models. The platform combined biomimetic circulation properties with tumor-directed penetration, producing stronger cellular uptake, apoptosis, migration inhibition, and tumor growth suppression than free photosensitizer alone.
-
Smoothened Agonist (SAG): Beyond Pathway Activation to Devel
2026-08-07
Discover how Smoothened Agonist (SAG), a potent Smoothened receptor agonist, advances Hedgehog pathway research and uniquely illuminates developmental biology—bridging molecular mechanism with assay strategy.
-
25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re
2026-08-06
Xiao et al. (2024) reveal that 25-hydroxycholesterol (25HC), produced by CH25H, accumulates in macrophage lysosomes to activate AMPKα, altering macrophage metabolism and promoting immunosuppressive tumor-associated phenotypes. This work uncovers a mechanistic link between oxysterol metabolism and tumor immune evasion, highlighting CH25H as a potential immunometabolic checkpoint for cancer immunotherapy.
-
DiscoveryProbe Protease Inhibitor Library: Applied Workflows
2026-08-06
The DiscoveryProbe Protease Inhibitor Library streamlines high throughput and high content screening with 825 rigorously validated inhibitors. This article explores practical workflows, troubleshooting strategies, and how recent mechanistic discoveries translate to real-world assay design.
-
Dynasore: Practical Use as a Dynamin GTPase Inhibitor in End
2026-08-05
Dynasore enables reversible, dose-dependent inhibition of dynamin GTPase activity, providing researchers with a direct method for dissecting dynamin-dependent endocytosis and vesicle trafficking. It is best used for mechanistic cell biology studies where acute, rapid blockade of vesicle scission is required; it is not suitable for applications demanding long-term inhibitor stability or aqueous solubility.
-
p-Cresyl Sulfate in Endothelial Dysfunction and Valve Calcif
2026-08-05
p-Cresyl sulfate, a principal uremic toxin, is a transformative tool for modeling cardiovascular complications in chronic kidney disease. This article details robust experimental workflows, troubleshooting insights, and the latest mechanistic advances leveraging p-tolyl hydrogen sulfate for vascular and valvular research.
-
Lipid Peroxidation (MDA) Assay Kit: Precision in Cancer Rese
2026-08-04
The Lipid Peroxidation (MDA) Assay Kit empowers researchers to robustly quantify malondialdehyde across diverse samples, supporting breakthrough studies in oxidative stress, ferroptosis, and drug resistance. Its dual-mode detection and assay stability set it apart for translational and mechanistic workflows.